Subscribe to RSS
DOI: 10.1055/s-2006-933100
A Novel Axially Chiral Phosphine-Oxazoline Ligand with an Axis-Unfixed Biphenyl Backbone: Preparation, Complexation, and Application in an Asymmetric Catalytic Reaction
Publication History
Publication Date:
10 March 2006 (online)
Abstract
A novel chiral phosphine-oxazoline ligand 3 with an axis-unfixed biphenyl backbone was prepared. This ligand existed as a mixture of two diastereomers in equilibrium in solution. However, when it was coordinated with palladium(II), only one of the two kinds of possible diastereomer complexes with different axial chirality was formed. When this axis-unfixed chiral ligand was used, up to 90% ee was attained for the palladium-catalyzed asymmetric allylic alkylation.
Key words
P,N-ligands - chiral biaryl ligands - oxazoline ligands - axial chirality - palladium-catalyzed allylic alkylation
-
1a
Bolm C. Angew. Chem., Int. Ed. Engl. 1991, 30: 542 -
1b
Pfaltz A. Acc. Chem. Res. 1993, 26: 339 -
1c
Togni A.Venanzi LM. Angew. Chem., Int. Ed. Engl. 1994, 33: 497 -
1d
Williams JMJ. Synlett 1996, 705 -
1e
Ghosh AK.Mathivanan P.Cappiello J. Tetrahedron: Asymmetry 1998, 9: 1 -
1f
Pfaltz A. Synlett 1999, 835 -
1g
Rechavi D.Lemaire M. Chem. Rev. 2002, 102: 3467 -
1h
Desimoni G.Faita G.Quadrelli P. Chem. Rev. 2003, 103: 3119 -
1i
McManus HA.Guiry PJ. Chem. Rev. 2004, 104: 4151 -
1j
Meyers AI. J. Org. Chem. 2005, 70: 6137 - Selected papers:
-
2a
Uozumi Y.Kato K.Hayashi T. J. Am. Chem. Soc. 1997, 119: 5063 -
2b
Uozumi Y.Kato K.Hayashi T. J. Org. Chem. 1998, 63: 5071 -
2c
Ogasawara M.Yoshida K.Kamei H.Kato K.Uozumi Y.Hayashi T. Tetrahedron: Asymmetry 1998, 9: 1779 -
2d
Uozumi Y.Kyota H.Kato K.Ogasawara M.Hayashi T. J. Org. Chem. 1999, 64: 1620 -
2e
Imai Y.Zhang W.Kida T.Nakatsuji Y.Ikeda I. Synlett 1999, 1319 -
2f
Kodama H.Ito J.Hori K.Ohta T.Furukawa I. J. Organomet. Chem. 2000, 603: 6 -
2g
Imai Y.Matsuo S.Zhang W.Nakatsuji Y.Ikeda I. Synlett 2000, 239 -
2h
Gladiali S.Loriga G.Medici S.Taras R. J. Mol. Catal. A: Chem. 2003, 196: 27 -
3a
Imai Y.Zhang W.Kida T.Nakatsuji Y.Ikeda I. Tetrahedron Lett. 1997, 38: 2681 -
3b
Imai Y.Zhang W.Kida T.Nakatsuji Y.Ikeda I. J. Org. Chem. 2000, 65: 3326 - 4
Imai Y.Zhang W.Kida T.Nakatsuji Y.Ikeda I. Tetrahedron Lett. 1998, 39: 4343 -
7a
Suzuki H. Bull. Chem. Soc. Jpn. 1959, 32: 1340 -
7b
Suzuki H. Electronic Absorption Spectra and Geometry of Organic Molecules Academic Press; New York: 1967. p.262 -
8a
Superchi S.Casarini K.Laurita A.Bavoso A.Rosini C. Angew. Chem. Int. Ed. 2001, 40: 451 -
8b
Isaksson R.Rashidi-Ranjbar P.Sandstrom J. J. Chem. Soc., Perkin Trans. 1 1991, 1147 - Selected reviews:
-
9a
Forst CG.Howarth J.Williams JMJ. Tetrahedron: Asymmetry 1992, 3: 1089 -
9b
Reiser O. Angew. Chem., Int. Ed. Engl. 1993, 32: 547 -
9c
von Matt P.Pfaltz A. Angew. Chem., Int. Ed. Engl. 1993, 32: 566 -
9d
Sprinz J.Helmchen G. Tetrahedron Lett. 1993, 34: 1769 -
9e
Trost BM.Van Vranken DL. Chem. Rev. 1996, 96: 395 -
10a
Åkermark B.Krakenberger B.Hansson S.Vitagliano A. Organometallics 1987, 6: 620 -
10b
Blochl PE.Togni A. Organometallics 1996, 15: 4125 -
10c
Pena-Cabrera E.Norrby PO.Sjogren M.Vitagliano A.De Felice V.Oslob J.Ishii S.O’Neill D.Åkermark B.Helquist P. J. Am. Chem. Soc. 1996, 118: 4299 -
11a
Auburn PR.Mackenzie PB.Bosnich B. J. Am. Chem. Soc. 1985, 107: 2033 -
11b
Mackenzie PB.Whelan J.Bosnich B. J. Am. Chem. Soc. 1985, 107: 2046 -
11c
Sawamura M.Ito Y. Chem. Rev. 1992, 92: 857 ; and references cited therein -
11d
Deng WP.You SL.Hou XL.Dai LX.Yu YH.Xia W.Sun J. J. Am. Chem. Soc. 2001, 123: 6508
References and Notes
Compound 3a: 1H NMR (400 MHz, CDCl3; major/minor = 57:43 in CDCl3): δ = 7.89 (dd, J = 1.5, 7.7 Hz, 1 H), 7.88 (dd, J = 1.5, 7.7 Hz, 1 H), 7.38-7.07 (m, 32 H), 6.89 (br d, J = 7.7 Hz, 1 H), 4.09 (dd, J = 8.4, 9.5 Hz, 1 H), 4.01 (dd, J = 6.6, 8.1 Hz, 1 H), 3.90-3.80 (m, 3 H), 3.69 (t, J = 8.4 Hz, 1 H), 1.71-1.62 (m, 1 H), 1.61-1.52 (m, 1 H), 0.84 (d, J = 7.0 Hz, 3 H), 0.80 (d, J = 7.0 Hz, 3 H), 0.84 (d, J = 6.9 Hz, 3 H). 31P NMR (CDCl3, PPh3 = -6.0 ppm): δ = -14.8 (major), -15.0 (minor). HRMS (EI): m/z calcd for C30H28NOP: 449.1910; found: 449.1905. Anal. Calcd for C31H30NOP: C, 80.16; H, 6.28; N, 3.12. Found: C, 79.78; H, 5.89; N, 3.11. [α]D
25 = -54.2 (c 0.48, CHCl3).
Compound 3b: 1H NMR (400 MHz, CDCl3, major/minor = 53:47 in CDCl3): δ = 7.89 (dd, J = 1.1, 7.7 Hz, 1 H), 7.88 (dd, J = 1.1, 7.7 Hz, 1 H), 7.39-7.07 (m, 32 H), 6.88 (br d, J = 8.1 Hz, 1 H), 6.83 (br d, J = 8.1 Hz, 1 H), 4.06-3.93 (m, 3 H), 3.89-3.75 (m, 3 H), 0.81 (s, 9 H), 0.73 (s, 9 H).
31P NMR (CDCl3, PPh3 = -6.0 ppm): δ = -14.9 (major), -15.0 (minor). HRMS (EI): m/z calcd for C31H30NOP: 463.2067; found: 463.2064. Anal. Calcd for C31H30NOP: C, 80.32; H, 6.52; N, 3.02. Found: C, 80.03; H, 6.62; N, 2.87. [α]D
25 -28.7 (c 0.52, CHCl3).
Complex 9 is formed with only one kind of axial chirality, but exists as a mixture of two diastereomers with W- and M-type.
Compound 9a: 1H NMR (400 MHz, CD2Cl2, major/minor = 54:46 in CD2Cl2): δ = 7.86-6.53 (m, 56 H), 5.91 (br d, J = 8.0 Hz, 1 H), 5.88 (br d, J = 7.6 Hz, 1 H), 5.80-5.68 (m, 2 H), 4.94 (d, J = 10.9 Hz, 1 H), 4.85 (d, J = 12.3 Hz, 1 H), 3.97-3.80 (m, 4 H), 3.34 (t, J = 9.4 Hz, 1 H), 2.48-2.38 (m, 1 H), 1.86-1.77 (m, 1 H), 1.50-1.40 (m, 1 H), 0.71 (d, J = 6.9 Hz, 3 H), 0.51 (d, J = 6.9 Hz, 3 H), 0.38 (d, J = 6.9 Hz, 3 H), 0.08 (d, J = 6.9 Hz, 3 H). 31P NMR (CD2Cl2, PPh3 = -6.0 ppm): δ = 28.8 (minor), 24.8 (major).
Compound 9b: 1H NMR (400 MHz, CD2Cl2, major/minor = 58:42 in CD2Cl2): δ = 7.87-6.58 (m, 55 H), 6.54 (dd, J = 11.2, 13.1 Hz, 1 H), 5.93-5.83 (m, 3 H), 5.53 (t, J = 10.9 Hz, 1 H), 4.94 (d, J = 11.2 Hz, 1 H), 4.80 (d, J = 12.3 Hz, 1 H), 4.03-3.96 (m, 2 H), 3.87 (dd, J = 9.1, 10.5 Hz, 1 H), 3.68 (dd, J = 5.4, 10.5 Hz, 1 H), 3.09 (t, J = 9.4 Hz, 1 H), 2.23 (br s, 1 H), 0.64 (s, 9 H), 0.43 (s, 9 H). 31P NMR (CD2Cl2, PPh3 = -6.0 ppm): δ = 29.1 (minor), 25.2 (major).